Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a trial of CP-866,087 in pre-menopausal women with female sexual arousal disorder
2006-005381-39Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CP-866087 in Sexual Arousal Disorder, sponsored by Pfizer. Started Feb 2007; status: completed.
02
Drugs
CP-866087
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on 2006-005381-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005381-39.